Inflammatory Muscle Diseases
The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
The four main types of inflammatory muscle disease — dermatomyositis, polymyositis, necrotizing autoimmune myositis, and inclusion-body myositis — are summarized. Pathogenesis, differential diagnosis, and treatment approaches are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Polymyositis and Dermatomyositis: (First of Two Parts)
Bohan, A., & Peter, J. B. (1975) · New England Journal of Medicine · doi:10.1056/nejm197502132920706 · Cited by 5,059
Polymyositis and dermatomyositis
Dalakas, M. C., & Hohlfeld, R. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14368-1 · Cited by 1,416
Self-citationFrequency of specific cancer types in dermatomyositis and polymyositis: a population-based study
Hill, C. L., Zhang, Y., Sigurgeirsson, B., Pukkala, E., Mellemkjaer, L., Airio, A., Evans, S. R., & Felson, D. T. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03540-6 · Cited by 1,191
Dalakas, M. C., Illa, I., Dambrosia, J. M., Soueidan, S. A., Stein, D. P., Otero, C., Dinsmore, S. T., & McCrosky, S. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292704 · Cited by 1,136
Self-citationPolymyositis and Dermatomyositis
Hohlfeld, R., Hofmann, W. W., & Hanley, D. F. (1994) · Neurocritical Care · doi:10.1007/978-3-642-87602-8_72 · Cited by 1,083
Hoogendijk, J. E., Amato, A. A., Lecky, B. R., Choy, E. H., Lundberg, I. E., Rose, M. R., Vencovsky, J., de Visser, M., & Hughes, R. A. (2004) · Neuromuscular Disorders · doi:10.1016/j.nmd.2004.02.006 · Cited by 950
Polymyositis, Dermatomyositis, and Inclusion-Body Myositis
Dalakas, M. C. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111213252107 · Cited by 938
Self-citationMitochondrial Myopathy Caused by Long-Term Zidovudine Therapy
Dalakas, M. C., Illa, I., Pezeshkpour, G. H., Laukaitis, J. P., Cohen, B., & Griffin, J. L. (1990) · New England Journal of Medicine · doi:10.1056/nejm199004193221602 · Cited by 844
Self-citationPolymyositis, Dermatomyositis, and Inclusion Body Myositis
Holton, J., Wedderburn, L. R., & Hanna, M. G. (2013) · UCL Discovery (University College London) · Cited by 764
Oddis, C. V., Reed, A. M., Aggarwal, R., Rider, L. G., Ascherman, D. P., Levesque, M. C., Barohn, R. J., Feldman, B. M., Harris‐Love, M. O., Koontz, D. C., et al. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37754 · Cited by 701
Mammen, A. L., Chung, T., Christopher-Stine, L., Rosen, P., Rosen, A., Doering, K. R., & Casciola-Rosen, L. A. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30156 · Cited by 699
Interferon‐α/β–mediated innate immune mechanisms in dermatomyositis
Greenberg, S. A., Pinkus, J. L., Pinkus, G. S., Burleson, T., Sanoudou, D., Tawil, R., Barohn, R. J., Saperstein, D. S., Briemberg, H. R., Ericsson, M., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20464 · Cited by 621
Microvascular changes in early and advanced dermatomyositis: A quantitative study
Emslie‐Smith, A. M., & Engel, A. G. (1990) · Annals of Neurology · doi:10.1002/ana.410270402 · Cited by 426
Treatment of inclusion-body myositis with IVIg: A double-blind, placebo-controlled study
Dalakas, M. C., Sonies, B., Dambrosia, J., Sekul, E., Cupler, E., & Sivakumar, K. (1997) · Neurology · doi:10.1212/wnl.48.3.712 · Cited by 350
Self-citationEmslie-Smith, A. M., Arahata, K., & Engel, A. G. (1989) · Human Pathology · doi:10.1016/0046-8177(89)90128-7 · Cited by 349
Nagaraju, K., Casciola‐Rosen, L., Lundberg, I., Rawat, R., Cutting, S., Thapliyal, R., Chang, J., Dwivedi, S., Mitsak, M., Chen, Y., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21103 · Cited by 336
Polymyositis: An overdiagnosed entity
van der Meulen, M. F. G., Bronner, I. M., Hoogendijk, J. E., Burger, H., van Venrooij, W. J., Voskuyl, A. E., Dinant, H. J., Linssen, W. H. J. P., Wokke, J. H. J., & de Visser, M. (2003) · Neurology · doi:10.1212/wnl.61.3.316 · Cited by 332
Engel, A. G., & Arahata, K. (1986) · Human Pathology · doi:10.1016/s0046-8177(86)80180-0 · Cited by 304
Cytosolic 5′‐nucleotidase 1A autoimmunity in sporadic inclusion body myositis
Benjamin Larman, H., Salajegheh, M., Nazareno, R., Lam, T., Sauld, J., Steen, H., Won Kong, S., Pinkus, J. L., Amato, A. A., Elledge, S. J., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23840 · Cited by 284
Aggarwal, R., Bandos, A., Reed, A. M., Ascherman, D. P., Barohn, R. J., Feldman, B. M., Miller, F. W., Rider, L. G., Harris‐Love, M. O., Levesque, M. C., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38270 · Cited by 281
Allenbach, Y., Drouot, L., Rigolet, A., Charuel, J. L., Jouen, F., Romero, N. B., Maisonobe, T., Dubourg, O., Behin, A., Laforet, P., et al. (2014) · Medicine · doi:10.1097/md.0000000000000028 · Cited by 278
Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches
Needham, M., & Mastaglia, F. L. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70171-0 · Cited by 269
Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM
Chahin, N., & Engel, A. G. (2008) · Neurology · doi:10.1212/01.wnl.0000277527.69388.fe · Cited by 258
Autoantibodies to cytosolic 5′‐nucleotidase 1A in inclusion body myositis
Pluk, H., van Hoeve, B. J. A., van Dooren, S. H. J., Stammen‐Vogelzangs, J., van der Heijden, A., Schelhaas, H. J., Verbeek, M. M., Badrising, U. A., Arnardottir, S., Gheorghe, K., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23822 · Cited by 256
Goebels, N., Michaelis, D., Engelhardt, M., Huber, S., Bender, A., Pongratz, D., Johnson, M. A., Wekerle, H., Tschopp, J., Jenne, D., et al. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118749 · Cited by 251
Evaluation and construction of diagnostic criteria for inclusion body myositis
Lloyd, T. E., Mammen, A. L., Amato, A. A., Weiss, M. D., Needham, M., & Greenberg, S. A. (2014) · Neurology · doi:10.1212/wnl.0000000000000642 · Cited by 247
Tacrolimus in refractory poly myositis with inter stitial lung disease
Oddis, C. V., Sciurba, F. C., Elmagd, K. A., & Starzl, T. E. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01927-3 · Cited by 245
Macrophagic myofasciitis: an emerging entity
Gherardi, R., Coquet, M., Chérin, P., Authier, F.-J., Laforêt, P., Bélec, L., Figarella-Branger, D., Mussini, J.-M., Pellissier, J.-F., & Fardeau, M. (1998) · The Lancet · doi:10.1016/s0140-6736(98)02326-5 · Cited by 244
Valiyil, R., Casciola‐Rosen, L., Hong, G., Mammen, A., & Christopher‐Stine, L. (2010) · Arthritis Care & Research · doi:10.1002/acr.20219 · Cited by 236
Sporadic inclusion body myositis—diagnosis, pathogenesis and therapeutic strategies
Dalakas, M. C. (2006) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0261 · Cited by 229
Self-citationEpidemiology of inclusion body myositis in the Netherlands: A nationwide study
Badrising, U. A., Maat-Schieman, M., van Duinen, S. G., Breedveld, F., van Doorn, P., van Engelen, B., van den Hoogen, F., Hoogendijk, J., Höweler, C., de Jager, A., et al. (2000) · Neurology · doi:10.1212/wnl.55.9.1385 · Cited by 214
Treatment of sporadic inclusion body myositis with bimagrumab
Amato, A. A., Sivakumar, K., Goyal, N., David, W. S., Salajegheh, M., Praestgaard, J., Lach-Trifilieff, E., Trendelenburg, A.-U., Laurent, D., Glass, D. J., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000001070 · Cited by 210
Sarcoplasmic redistribution of nuclear TDP‐43 in inclusion body myositis
Salajegheh, M., Pinkus, J. L., Taylor, J. P., Amato, A. A., Nazareno, R., Baloh, R. H., & Greenberg, S. A. (2009) · Muscle & Nerve · doi:10.1002/mus.21386 · Cited by 203
A 12-year follow-up in sporadic inclusion body myositis: an end stage with major disabilities
Cox, F. M., Titulaer, M. J., Sont, J. K., Wintzen, A. R., Verschuuren, J. J. G. M., & Badrising, U. A. (2011) · Brain · doi:10.1093/brain/awr217 · Cited by 201
Chimerism in children with juvenile dermatomyositis
Reed, A. M., Picornell, Y. J., Harwood, A., & Kredich, D. W. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03500-5 · Cited by 200
Schmidt, J., Barthel, K., Wrede, A., Salajegheh, M., Bähr, M., & Dalakas, M. C. (2008) · Brain · doi:10.1093/brain/awn053 · Cited by 198
Self-citationReview: An update on inflammatory and autoimmune myopathies: Inflammatory myopathies
Dalakas, M. C. (2011) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01153.x · Cited by 195
Self-citationImmunobiology of muscle: advances in understanding an immunological microenvironment
Wiendl, H., Hohlfeld, R., & Kieseier, B. C. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.05.003 · Cited by 195
Rider, L. G. (2011) · JAMA · doi:10.1001/jama.2010.1977 · Cited by 177
Ernste, F. C., & Reed, A. M. (2013) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2012.10.017 · Cited by 169
Inclusion body myositis in HIV-1 and HTLV-1 infected patients
Cupler, E., Leon‐Monzon, M., Miller, J. D., et al. (1996) · Brain · doi:10.1093/brain/119.6.1887 · Cited by 146
Acquired immune and inflammatory myopathies
Pestronk, A. (2011) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32834bab42 · Cited by 143
Casciola-Rosen, L. A., & Mammen, A. L. (2012) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e328358bd85 · Cited by 140
Role of cytokines and chemokines in idiopathic inflammatory myopathies
Paepe, B. D., Creus, K. K., & Bleecker, J. D. (2009) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3283317b31 · Cited by 135
Subcutaneous immunoglobulin in polymyositis and dermatomyositis: A novel application
Danieli, M. G., Pettinari, L., Moretti, R., Logullo, F. O., & Gabrielli, A. (2010) · Autoimmunity Reviews · doi:10.1016/j.autrev.2010.09.004 · Cited by 123
Intravenous immunoglobulin for dysphagia of inclusion body myositis
Cherin, P., Pelletier, S., Teixeira, A., Laforêt, P., Simon, A., Herson, S., & Eymard, B. (2002) · Neurology · doi:10.1212/wnl.58.2.326 · Cited by 122
Therapeutic effect of tocilizumab on two patients with polymyositis
Narazaki, M., Hagihara, K., Shima, Y., Ogata, A., Kishimoto, T., & Tanaka, T. (2011) · Lara D. Veeken · doi:10.1093/rheumatology/ker152 · Cited by 122
Hofbauer, M., Wiesener, S. C., Babbe, H., Roers, A., Wekerle, H., Dornmair, K., Hohlfeld, R., & Goebels, N. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0236183100 · Cited by 121
Mechanisms of Disease: signaling pathways and immunobiology of inflammatory myopathies
Dalakas, M. C. (2006) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0140 · Cited by 121
Self-citationAskanas, V., Engel, W. K., & Nogalska, A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.09.005 · Cited by 120
Wiendl, H., Mitsdoerffer, M., Schneider, D., Melms, A., Lochmuller, H., Hohlfeld, R., & Weller, M. (2003) · Brain · doi:10.1093/brain/awg114 · Cited by 119
Altered RIG ‐I/ DDX58 ‐mediated innate immunity in dermatomyositis
Suárez‐Calvet, X., Gallardo, E., Nogales‐Gadea, G., Querol, L., Navas‐Madroñal, M., Díaz‐Manera, J., Rojas‐García, R., & Illa, I. (2014) · The Journal of Pathology · doi:10.1002/path.4346 · Cited by 113
Dermatomyositis, polymyositis and immune-mediated necrotising myopathies
Luo, Y., & Mastaglia, F. L. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.05.034 · Cited by 112
Nuclear actin aggregation is a hallmark of anti-synthetase syndrome–induced dysimmune myopathy
Stenzel, W., Preuße, C., Allenbach, Y., Pehl, D., Junckerstorff, R. C., Heppner, F. L., Nolte, K. W., Aronica, E., Kana, V., Rushing, E. J., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001422 · Cited by 107
Stenzel, W., Goebel, H. H., & Aronica, E. (2012) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2012.01302.x · Cited by 106
Schmidt, J., Rakočević, G., Raju, R. P., & Dalakas, M. C. (2004) · Brain · doi:10.1093/brain/awh148 · Cited by 104
Self-citationBrady, S., Squier, W., Sewry, C. A., Hanna, M. G., Hilton‐Jones, D., & Holton, J. L. (2014) · BMJ Open · doi:10.1136/bmjopen-2013-004552 · Cited by 102
Dalakas, M. C., Rakočević, G., Shatunov, A., Goldfarb, L. G., Raju, R. P., & Salajegheh, M. K. (2007) · Annals of Neurology · doi:10.1002/ana.21103 · Cited by 96
Self-citationSchmidt, J., Barthel, K., Zschüntzsch, J., Muth, I. E., Swindle, E. J., Hombach, A., Sehmisch, S., Wrede, A., Lühder, F., Gold, R., et al. (2012) · Brain · doi:10.1093/brain/aws046 · Cited by 71
Self-citationA review on the association between inflammatory myopathies and vaccination
Stübgen, J. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.08.005 · Cited by 70
Cutaneous Dermatomyositis: An Updated Review of Treatment Options and Internal Associations
Femia, A. N., Vleugels, R. A., & Callen, J. P. (2013) · American Journal of Clinical Dermatology · doi:10.1007/s40257-013-0028-6 · Cited by 64
Ivanidze, J., Hoffmann, R. F. G., Lochmüller, H., Engel, A. G., Hohlfeld, R., & Dornmair, K. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.05.055 · Cited by 60
Target Specificity of an Autoreactive Pathogenic Human γδ-T Cell Receptor in Myositis
Bruder, J., Siewert, K., Obermeier, B., Malotka, J., Scheinert, P., Kellermann, J., Ueda, T., Hohlfeld, R., & Dornmair, K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.356709 · Cited by 58
Dalakas, M. C. (2008) · Annals of Neurology · doi:10.1002/ana.21452 · Cited by 53
Self-citationClinical Features in Patients with Long-Lasting Macrophagic Myofasciitis
Rigolet, M., Aouizerate, J., Couette, M., Ragunathan-Thangarajah, N., Aoun-Sebaiti, M., Gherardi, R. K., Cadusseau, J., & Authier, F. J. (2014) · Frontiers in Neurology · doi:10.3389/fneur.2014.00230 · Cited by 51
Moran, E. M., & Mastaglia, F. L. (2014) · Neuromuscular Disorders · doi:10.1016/j.nmd.2014.06.432 · Cited by 32
Improving Undergraduate Musculoskeletal Education: A Continuing Challenge
Thompson, A. (2008) · The Journal of Rheumatology · doi:10.3899/jrheum.080972 · Cited by 24
Entering a new phase of immunogenetics in the idiopathic inflammatory myopathies
Rothwell, S., Cooper, R. G., Lamb, J. A., & Chinoy, H. (2013) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000434676.70268.66 · Cited by 23
Research works printed but not linked: 17
- 10.1007/s11926-013-0359-6 · doi:10.1007/s11926-013-0359-6
- 10.1186/ar2987 · doi:10.1186/ar2987
- Wilson FC, 2008, J Rheumatol, 35, 445
- 10.1016/j.lpm.2011.01.005 · doi:10.1016/j.lpm.2011.01.005
- 10.1002/art.38093 · doi:10.1002/art.38093
- 10.1084/jem.181.5.1863 · doi:10.1084/jem.181.5.1863
- 10.4049/jimmunol.178.1.547 · doi:10.4049/jimmunol.178.1.547
- 10.1038/nrrheum.2010.2 · doi:10.1038/nrrheum.2010.2
- 10.1016/S0967-5868(02)00271-0 · doi:10.1016/s0967-5868(02)00271-0
- 10.1136/ard.2007.077974 · doi:10.1136/ard.2007.077974
- 10.1136/annrheumdis-2012-202857 · doi:10.1136/annrheumdis-2012-202857
- Taborda AL, 2014, Clin Exp Rheumatol, 32, 188
- 10.1093/brain/awr213 · doi:10.1093/brain/awr213
- 10.1093/brain/awp104 · DOI
- 10.1016/j.jns.2013.08.007 · doi:10.1016/j.jns.2013.08.007
- 10.1136/annrheumdis-2013-eular.527 · doi:10.1136/annrheumdis-2013-eular.527
- 10.1007/s11926-012-0248-4 · doi:10.1007/s11926-012-0248-4
Cited by
Lundberg, I. E., Tjärnlund, A., Bottai, M., Werth, V. P., Pilkington, C., Visser, M. D., Alfredsson, L., Amato, A. A., Barohn, R. J., Liang, M. H., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-211468 · Cited by 1,557
Lundberg, I. E., Tjärnlund, A., Bottai, M., Werth, V. P., Pilkington, C., de Visser, M., Alfredsson, L., Amato, A. A., Barohn, R. J., Liang, M. H., et al. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40320 · Cited by 730
Classification and management of adult inflammatory myopathies
Selva-O'Callaghan, A., Pinal-Fernandez, I., Trallero-Araguás, E., Milisenda, J. C., Grau-Junyent, J. M., & Mammen, A. L. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30254-0 · Cited by 430
Complement in neurological disorders and emerging complement-targeted therapeutics
Dalakas, M. C., Alexopoulos, H., & Spaeth, P. J. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0400-0 · Cited by 363
Self-citationRecent Issues on Body Composition Imaging for Sarcopenia Evaluation
Lee, K., Shin, Y., Huh, J., Sung, Y. S., Lee, I.-S., Yoon, K.-H., & Kim, K. W. (2019) · Korean Journal of Radiology · doi:10.3348/kjr.2018.0479 · Cited by 336
Metadata
- Authors
- Dalakas, M. C.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2015-04-30
- Volume
- 372
- Issue
- 18
- Pages
- 1734-1747
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2159985097
- Cited by
- 790
- References
- 68
- FWCI
- 53.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.